| Aug'19 | Aug'18 | Aug'17 | Aug'16 | Aug'15 | Aug'13 | Aug'12 | Aug'11 | Aug'10 |
|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | ||||||||
Net income (loss) | ||||||||
-3,565 | -2,981 | -4,104 | -21,304 | -13,318 | -44,638 | -49,949 | -16,138 | 10,828 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | ||||||||
1,093 | 998 | 1,096 | 5,526 | 4,969 | 8,317 | 8,677 | 6,663 | 4,695 |
Goodwill impairment | ||||||||
- | - | - | 55 | - | 1,077 | 0 | - | - |
Impairment of long-lived assets | ||||||||
- | - | - | 8,635 | - | - | - | - | - |
Impairment of long-lived assets | ||||||||
- | - | - | - | - | 10,923 | 7,507 | - | - |
Impairment loss on investments | ||||||||
- | - | 352 | 597 | 0 | 1,885 | - | - | - |
Stock-based compensation expense | ||||||||
149 | 141 | 25 | 382 | 1,289 | 2,020 | 2,616 | 1,785 | 247 |
Bad debt expense | ||||||||
0 | 10 | 42 | 125 | 74 | 1,071 | 1,405 | 1,196 | 100 |
Provisions for inventory write-downs | ||||||||
743 | 695 | 1,506 | 1,542 | 1,400 | 3,226 | 3,148 | 5,793 | 40 |
Equity in loss from unconsolidated entities | ||||||||
- | 8 | 11 | - | - | - | - | - | - |
Equity in loss from unconsolidated entities | ||||||||
- | - | - | -79 | -56 | -249 | -13,619 | -3,126 | -313 |
Gain on disposals of long-lived assets, net | ||||||||
288 | 902 | 149 | 23 | 221 | -417 | 125 | - | 15 |
Bargain purchase gain on acquisition | ||||||||
- | - | - | - | - | - | - | - | 349 |
Income recognized on patents assignment | ||||||||
- | 499 | - | - | - | 51 | 51 | 17 | - |
Changes in : | ||||||||
Accounts receivable | ||||||||
427 | -801 | 202 | -1,042 | 165 | -1,650 | 773 | -1,992 | 4,872 |
Inventories | ||||||||
987 | -393 | 205 | -380 | -1,430 | 579 | 445 | 8,132 | 3,463 |
Prepaid expenses and other | ||||||||
145 | -129 | -351 | -281 | -531 | -43 | -369 | 854 | 1,810 |
Accounts payable | ||||||||
-185 | -84 | -191 | -85 | -624 | 292 | 421 | -595 | 1,501 |
Accrued expenses and other current liabilities | ||||||||
66 | 114 | -641 | -671 | 54 | -363 | -2,190 | 3,131 | 1,307 |
Net cash used in operating activities | ||||||||
-3,546 | -1,177 | -2,109 | - | - | - | - | - | - |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||||||||
Net cash provided by (used in) operating activities | ||||||||
- | - | - | -3,439 | -4,525 | -14,461 | -15,771 | -2,050 | 8,522 |
Purchases of property, plant and equipment | ||||||||
127 | 341 | 150 | 821 | 1,574 | 2,716 | 11,569 | 21,462 | 9,807 |
Proceeds from sales of property, plant and equipment | ||||||||
502 | 1,004 | 149 | 357 | 123 | - | 218 | - | 54 |
Proceeds from sale of investment | ||||||||
- | 54 | 59 | - | - | - | - | - | - |
Proceeds from sale of short-term investments | ||||||||
- | - | - | - | - | 8,831 | - | - | - |
Proceeds from return of investment in unconsolidated entity | ||||||||
- | - | - | - | - | 250 | - | - | - |
Decrease in restricted cash | ||||||||
- | - | - | - | -334 | - | - | - | - |
Proceeds from patents assignment | ||||||||
- | 500 | - | - | - | - | - | 540 | - |
Return the received-in-advance | ||||||||
3,000 | - | - | - | - | - | - | - | - |
Purchase of investments | ||||||||
- | - | - | - | - | 2,873 | - | 993 | 15,530 |
Payments related to acquisition of business | ||||||||
- | - | - | - | - | 888 | - | 1,330 | 922 |
Purchase of short-term investments | ||||||||
- | - | - | - | - | - | 8,831 | - | - |
Payments for development of intangible assets | ||||||||
3 | 4 | 25 | 54 | 49 | 429 | 368 | 270 | 235 |
Other investing activities | ||||||||
- | - | 2 | 17 | -26 | -5 | -17 | 125 | -50 |
Net cash used in investing activities | ||||||||
-2,628 | 1,213 | 31 | - | - | - | - | - | - |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||||||||
Net cash provided by (used in) investing activities | ||||||||
- | - | - | -535 | -1,140 | 2,180 | -20,533 | -23,640 | -26,390 |
Proceeds from issuance of common stock | ||||||||
- | - | - | 2,885 | - | - | - | 92,702 | - |
Proceeds from long-term debt | ||||||||
6,385 | - | - | - | - | 4,024 | - | 2,896 | 1,481 |
Repayments of long-term debt | ||||||||
2,330 | 331 | 323 | 1,065 | 1,808 | 1,453 | 948 | 883 | 485 |
Proceeds from issuance of Series E convertible preferred stock | ||||||||
- | - | - | - | - | - | - | - | 15,043 |
Proceeds from exercise of stock options | ||||||||
- | - | - | - | - | 74 | 73 | 82 | 250 |
Proceeds from line of credit | ||||||||
- | - | - | - | - | - | 1,594 | 3,752 | 2,186 |
Payments on line of credit | ||||||||
- | - | - | - | - | 1,623 | 900 | 3,928 | 1,144 |
Proceeds from loan from related party | ||||||||
- | - | - | - | - | 204 | - | - | - |
Acquisition of noncontrolling interests | ||||||||
1 | - | 46 | - | - | 202 | - | - | - |
Net cash provided by financing activities | ||||||||
4,054 | -331 | -369 | - | - | - | - | - | - |
Effect of exchange rate changes on cash and cash equivalents | ||||||||
79 | 132 | -1 | - | - | - | - | - | - |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ||||||||
-2,041 | -163 | - | - | - | - | - | - | - |
Other financing activities | ||||||||
- | - | - | 3,500 | - | - | - | - | - |
Net cash used in financing activities | ||||||||
- | - | - | 5,320 | -1,808 | 1,024 | -181 | 94,621 | 17,331 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||
- | - | - | -124 | -368 | 301 | 94 | 1,168 | 342 |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | ||||||||
- | - | -2,448 | 1,222 | -7,841 | - | - | - | - |
NET DECREASE IN CASH AND CASH EQUIVALENTS | ||||||||
- | - | - | - | - | -10,956 | -36,391 | 70,099 | -195 |
Cash paid for interest | ||||||||
39 | 43 | 47 | 60 | 105 | 153 | 129 | 124 | 65 |
Cash paid for income taxes | ||||||||
- | - | 3 | 3 | 5 | 17 | 51 | 617 | 4 |
NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
Accrual related to property, plant and equipment | ||||||||
56 | 67 | 217 | 257 | 522 | 511 | 3,142 | 2,168 | 916 |
Proceeds from sale of property, plant and equipment included in other current liabilities | ||||||||
- | - | - | - | 884 | - | - | - | - |
Accrual related to acquisition of business | ||||||||
- | - | - | - | - | 2,049 | - | - | - |